LogicBio Therapeutics LOGC
$ 6.95
0.65%
Quarterly report 2022-Q3
added 11-14-2022
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Frederic Chereau |
Employees in the company |
41 |
Shares |
32.4 M |
Market Cap[1] |
$ 225 M |
EBITDA (LTM) |
$ -25.6 M |
P/E (LTM) |
-2.46 |
P/S (LTM) |
6.29 |
EPS (LTM) |
-0.84 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.